Shalash, A.O.; Azuar, A.; Madge, H.Y.R.; Modhiran, N.; Amarilla, A.A.; Liang, B.; Khromykh, A.A.; Hussein, W.M.; Chappell, K.J.; Watterson, D.;
et al. Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems. Pharmaceutics 2022, 14, 856.
https://doi.org/10.3390/pharmaceutics14040856
AMA Style
Shalash AO, Azuar A, Madge HYR, Modhiran N, Amarilla AA, Liang B, Khromykh AA, Hussein WM, Chappell KJ, Watterson D,
et al. Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems. Pharmaceutics. 2022; 14(4):856.
https://doi.org/10.3390/pharmaceutics14040856
Chicago/Turabian Style
Shalash, Ahmed O., Armira Azuar, Harrison Y. R. Madge, Naphak Modhiran, Alberto A. Amarilla, Benjamin Liang, Alexander A. Khromykh, Waleed M. Hussein, Keith J. Chappell, Daniel Watterson,
and et al. 2022. "Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems" Pharmaceutics 14, no. 4: 856.
https://doi.org/10.3390/pharmaceutics14040856
APA Style
Shalash, A. O., Azuar, A., Madge, H. Y. R., Modhiran, N., Amarilla, A. A., Liang, B., Khromykh, A. A., Hussein, W. M., Chappell, K. J., Watterson, D., Young, P. R., Skwarczynski, M., & Toth, I.
(2022). Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems. Pharmaceutics, 14(4), 856.
https://doi.org/10.3390/pharmaceutics14040856